The Prognostic Value of 18F-FDG PET/CT Taken Immediately After Completion of Radiotherapy for Lung Cancer Treated with Concurrent Chemoradiotherapy: A Pilot Study
Not Applicable
- Conditions
- ung cancer
- Registration Number
- JPRN-UMIN000037493
- Lead Sponsor
- Juntendo University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have a history of radiotherapy to the chest Patients with recurrent lung cancer.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the SUVmax of PET/CT taken within 24hours of completing radiotherapy and PET/CT taken 2-9 month after completing radiotherapy and assessing the efficacy of PET/CT taken immediately after completion of radiotherapy.
- Secondary Outcome Measures
Name Time Method